February, 26 2026 Thursday 08:38 Hrs
Last update 11-9-2025
  • SENSEX :   82,276.07

  • Commodity broking firm in India50.15( 0.06%) 25-Feb-2026
top-arrow-market
Sensex 82276.07 50.15  (0.06) 25-Feb-2026
Previous Day Close
82225.92
Today's High/Low
High Low
  •  
  •  
82957.91 82132.63

NSE Announcements

5paisa Capital Ltd

5Paisa Capital will hold a meeting of the Board of Directors of the Company on 28 February 2026.
Ahasolar Technologies Ltd

Ahasolar Technologies will hold a meeting of the Board of Directors of the Company on 5 March 2026.
Arcee Industries Ltd

Arcee Industries will hold a meeting of the Board of Directors of the Company on 27 February 2026.
Ashiana Ispat Ltd

Ashiana Ispat announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 25 March 2026.
Ashoka Buildcon Ltd

Ashoka Buildcon announced that ACUITE Ratings & Research has updated the credit rating for both long-term and short-term debt of the Company as ‘ACUITE AA (Stable) (Reaffirmed) – ‘Removed from Rating Watch' and ACUITE A1+ (Reaffirmed) ‘Removed from Rating Watch' respectively.
Astonea Labs Ltd

Astonea Labs will hold a meeting of the Board of Directors of the Company on 27 February 2026.
Athena Global Technologies Ltd

Athena Global Technologies announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 25 March 2026.
AXISCADES Technologies Ltd

AXISCADES Technologies signed an agreement at the Embassy of France, New Delhi in the presence of  Eléonore Caroit, Minister Delegate to the Minister for Europe and Foreign Affairs, as a part of the delegation of Emmanuel Macron, President of the French Republic, to India, for enhancing India's capability in Space Situational Awareness.

Bharat Electronics Ltd

Bharat Electronics has received orders worth Rs 733 crore. Major orders received include TR modules, communication equipment, encryptors, radars, jammers, software solutions, test equipment, upgrades, spares, services etc.
Biocon Ltd

Biocon has received approval from the U.S. FDA, for its complex formulation Liraglutide Injection, 18 mg/3 mL (6 mg/mL) single-patient-use prefilled pens (gSaxenda®).

Liraglutide is a drug-device combination formulation used in the treatment of chronic weight management, indicated as an adjunct to a reduced-calorie diet and increased physical activity.

GLP-1 receptor agonists have emerged as one of the fastest growing therapeutic classes globally, driven by the rising prevalence of obesity and metabolic disorders, strong clinical outcomes, and increasing physician adoption.

Top
Attention Investor:
Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.